Symbol="EDIT"
AssetType="Common Stock"
Name="Editas Medicine Inc"
Description="Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1650664"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11 HURLEY ST., CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="715918000"
EBITDA="-209756992"
PERatio="None"
PEGRatio="0"
BookValue="5.03"
DividendPerShare="0"
DividendYield="0"
EPS="-2.97"
RevenuePerShareTTM="0.278"
ProfitMargin="0"
OperatingMarginTTM="-11.18"
ReturnOnAssetsTTM="-0.24"
ReturnOnEquityTTM="-0.476"
RevenueTTM="19316000"
GrossProfitTTM="-155246000"
DilutedEPSTTM="-2.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.546"
AnalystTargetPrice="13.18"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="26.38"
PriceToBookRatio="1.718"
EVToRevenue="12.25"
EVToEBITDA="-1.587"
Beta="1.804"
num_52WeekHigh="16.39"
num_52WeekLow="6.33"
num_50DayMovingAverage="8.63"
num_200DayMovingAverage="9.05"
SharesOutstanding="81526000"
DividendDate="None"
ExDividendDate="None"
symbol="EDIT"
open="8.82"
high="8.93"
low="8.55"
price="8.77"
volume="1051267.00"
latest_trading_day="2023-08-25"
previous_close="8.81"
change="-0.04"
change_percent="-0.4540%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="44"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="1955052"
Change_recent_avg="0.02"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0051.jpeg"
image_negative_thumbnail_id_2="1108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="958"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0120.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
